Alnylam Pharmaceuticals
ALNY
#534
Rank
โ‚น4.120 T
Marketcap
โ‚น31,193
Share price
0.88%
Change (1 day)
31.26%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company